A
Amylyx Pharmaceuticals, Inc.
AMLX · NASDAQ · Healthcare · 2.4B
Closing price
$28.14
+3.46% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
—
Price / net assetsP/B
8.7×
Enterprise value / EBITDAEV/EBITDA
-16.9×
Free cash flow yieldFCF yield
-4.6%
Return on equityROE
-47.4%
Operating margin
—
Net debt / EBITDAbalance-sheet strength
1.5×
Interest coverage
—
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.